Haematology (incl blood transfusion)

Showing results 1 - 10 of 100

Sorted by most recent

TitleAuthorDate

Development and evaluation of a national administrative code-based system for estimation of hospital-acquired venous thromboembolism in Ireland

Ciara Kirke, Richard Daly, Therese Dalchan, Jacqui Curley, Ruth Buckley, Deirdre Lynch, Maeve P Crowley, Barry Kevane, Emer Gallagher, Ann Marie O’Neill, Fionnuala Ní Áinle

20 February 2025

Prevalence of pulmonary dysfunction and its risk factors in patients with transfusion-dependent thalassaemia: protocol for a systematic review and meta-analysis

Xiao Liang, Yanfei Lu, Yumei Huang, Lingyuan Pan, Min Wu, Yongrong Lai, Rongrong Liu

18 February 2025

Hepatic and renal functions of paediatric patients with thalassaemia: a cross-sectional study from two large thalassaemia centres in Sri Lanka

Wasana Wijenayake, Raveen Thennakoon, Hashan Pathiraja, Dayananda Bandara, Roshitha De Silva, Anuja Premawardhena, Meranthi Fernando, Sachith Mettananda

6 February 2025

Multicentre adaptive randomised trial of GvHD prophylaxis following unrelated donor stem cell transplantation comparing Thymoglobulin versus calcineurin inhibitor-based or sirolimus-based post-transplant cyclophosphamide (Methods of T cell Depletion, MoTD trial)

Ronjon Chakraverty, Emma Kempshall, Fiona Dignan, Adrian Bloor, Matthew Collin, Kavita Raj, Jeff Davies, Victoria Potter, Ram Malladi, Siobhan Smith, Simon Gates, Charlotte Gaskell, Rebecca Bishop, Andrea Hodgkinson, Gabrielle Smith

28 January 2025

HINODE study: haemophilia A in infancy and newborns – protocol for a prospective, multicentre, observational study evaluating the coagulation potential and safety of emicizumab prophylaxis

Shouichi Ohga, Masahiro Takeyama, Masataka Ishimura, Hirosuke Inoue, Daisuke Nosaka, Keisuke Iwasaki, Chika Mitsui, Keiji Nogami

26 December 2024

Intestinal Microbiota Transplant Prior to Allogeneic Stem Cell Transplant (MAST) trial: study protocol for a multicentre, double-blinded, placebo-controlled, phase IIa trial

Benjamin H Mullish, Andrew J Innes, Lauren A Roberts, Shian Anim-Burton, Lee Webber, Nicholas A Johnson, Rohma Ghani, Pakhshan Farshi, Anjum B Khan, Francesca Kinsella, Panagiotis Kottaridis, Pramila Krishnamurthy, Emma Nicholson, Renuka Palanicawandar, Graham WheelerSee the full list of authors

22 December 2024

Protocol for a multicentric, double-blind, randomised controlled trial of hyperbaric oxygen therapy (HBOT) versus sham for treating vaso-occlusive crisis (VOC) in sickle cell disease (SCD) in patients aged 8 years or older (HBOT-SCD study)

Jerome Stirnemann, Jacques Serratrice, Tamara Mann, Pierre Louge, Combescure Christophe, Kaveh Samii, Rodrigue Pignel, Thomas Agoritsas, Marc Ansari, Giovanna Cannas, Yves Chalandon, Laurent Cimasoni, Pierre Cougoul, Benoit Desgraz, Alain GervaixSee the full list of authors

28 November 2024

Temporal changes in the burden of leukaemia and lymphoma in the Australasia and Oceania regions, 2010–2019: an analysis of the Global Burden of Disease Study 2019

Thi Quynh Anh Ho, Peter Lee, Lan Gao

27 November 2024

Factors influencing blood donation among university students in Vojvodina, Serbia: cross-sectional study

Neda Kocic, Nevenka Bujandric, Zorana Budakov Obradovic, Jasmina Grujic, Milomir Bezanovic, Jovanka Kolarovic

18 November 2024

Identifying thresholds for meaningful improvements in NTDT-PRO scores to support conclusions about treatment benefit in clinical studies of patients with non-transfusion-dependent beta-thalassaemia: analysis of pooled data from a phase 2, double-blind, placebo-controlled, randomised trial

Ali T Taher, Khaled M Musallam, Vip Viprakasit, Antonis Kattamis, Jennifer Lord-Bessen, Aylin Yucel, Shien Guo, Christopher G Pelligra, Alan L Shields, Jeevan K Shetty, Mrudula B Glassberg, Luciana Moro Bueno, Maria Domenica Cappellini

14 November 2024

12 3 4 5 6 7 8 9 10 Next